Does TICAGRELOR Cause Product packaging quantity issue? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product packaging quantity issue have been filed in association with TICAGRELOR (Ticagrelor). This represents 0.0% of all adverse event reports for TICAGRELOR.
6
Reports of Product packaging quantity issue with TICAGRELOR
0.0%
of all TICAGRELOR reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From TICAGRELOR?
Of the 6 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TICAGRELOR. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TICAGRELOR Cause?
Dyspnoea (3,156)
Myocardial infarction (1,749)
Death (1,510)
Off label use (1,084)
Fatigue (1,081)
Chest pain (1,075)
Contusion (970)
Dizziness (811)
Vascular stent thrombosis (700)
Haemorrhage (676)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which TICAGRELOR Alternatives Have Lower Product packaging quantity issue Risk?
TICAGRELOR vs TICLOPIDINE
TICAGRELOR vs TIGECYCLINE
TICAGRELOR vs TIKOSYN
TICAGRELOR vs TILDRAKIZUMAB
TICAGRELOR vs TILDRAKIZUMAB-ASMN